现代政府建设的方向选择

在新一轮政府体制改革中 ,政府职能转变是被当作主题和重点凸显的。在新的形势下 ,如何通过政府职能转变塑造一个行为规范、运转协调、公正透明、廉洁高效的现代政府 ,这是一个需要进行深层研究和探析的问题。     

Priorities Above All

正Overcoming COVID-19 and restoring normality top the agenda for Asia-Pacific region Leaders from 21 members of the AsiaPacific Economic Cooperation(APEC) forum emphasized more effort is needed to contain the COVID-19 pandemic and restart the regional economy at a virtual meeting on July 16. As some of the economies, including Indonesia,     

PARADISE FOR GIANT PANDAS

正Almost perished, pandas now enjoy a happy life as protection rises to the next level The world's only captive brown giant panda, Qi Zai, made its public debut in late May, during the trial operation of a science park in Xi'an, Shaanxi Province. Twelve years ago, it was found as a weak and neglected cub in a national nature reserve in Foping County, Hanzhong City of the province.     

基于抗原蛋白Fiber-2及细胞因子佐剂的Ⅰ群4型禽腺病毒亚单位疫苗的开发

为了开发一种抗I群4型禽腺病毒(FAd V-4)的亚单位疫苗,选择I群禽腺病毒血清4型流行毒株衣壳蛋白Fiber-2作为保护性抗原蛋白。利用昆虫细胞-杆状病毒系统生产Fiber-2蛋白,通过Westernblot检测重组蛋白的表达情况,利用双向琼脂扩散法检测重组Fiber-2的免疫原性。为了增强亚单位疫苗的免疫保护效果,添加鸡源白细胞介素2(chIL-2)和鸡源γ-干扰素(ch IFN-γ)作为免疫佐剂,与重组Fiber-2单独或混合使用,制备多种形式的亚单位疫苗,并进行动物攻毒保护试验。重组蛋白的Western-blot鉴定结果显示,63 ku处出现Fiber-2蛋白目的条带;双向琼脂扩散试验结果显示,重组蛋白效价达到1∶128,表现出良好的反应原性。动物攻毒保护试验结果显示,单独使用Fiber-2免疫SPF鸡,在50 μg/只的剂量下,可为SPF鸡提供100%的保护效果,以chIL-2和chIFN-γ为免疫佐剂,与重组Fiber-2联合免疫SPF鸡,可显著增强Fiber-2在低剂量(10 μg/只)下的免疫保护效果,上述结果表明重组Fiber-2联合chIL-2和chIFN-γ细胞因子佐剂所制备的亚单位疫苗在抗I群4型禽腺病毒感染领域具有良好的应用前景。     

新《民事证据规定》视角下鉴定人制度定位问题研究

鉴定人角色定位是鉴定人制度中的一个基本问题,它决定着鉴定人的制度设计及鉴定人在诉讼中的权利、义务以及责任的承担。从比较法角度看,英美法系国家的专家证人属于证人,具有党派性的特征。大陆法系国家在鉴定人角色定位问题上有不同的观点。通过梳理发现,这些观点可总结为证据方法说、证据调查说和折衷说三种。在我国,经过民事诉讼立法及相关司法解释的相继出台,鉴定人定位问题的脉络越来越清晰。2019年12月,新《民事证据规定》颁布,鉴定人定位的明晰成为理解、适用新《民事证据规定》鉴定人制度的前提。术语上的届分、内容上的区别是制度完善的基础,"双重属性"下其他专家制度的配套适用也是问题解决的路径。     

反垄断法上专利强制许可抗辩的德国经验与启示

为弥补专利法强制许可保护竞争的不足,德国学界与法院认可了反垄断法上专利强制许可的存在,进而在司法实践中发展出专利强制许可抗辩。专利强制许可抗辩的本质是一种特殊的利益平衡路径,不仅可协调反垄断法与知识产权法的紧张关系,有效保证专利权人与需求人之间的利益平衡,且有利于诉讼成本的节省。从权利保护的及时性及竞争秩序维护的必要性角度出发,我国应采纳专利强制许可抗辩,并完成要件的厘清。     

CONCERTED EFFORTS

Since the outbreak of the novel coronavirus(2019-nGoV),China has carried out close cooperation with international organizations and governments on many fronts,including data-sharing,information notification and citizen evacuation,to curb the virus'global spread.     

RACING AGAINST TIME

On December 29,2019,seven cases of pneumonia of unknown cause were referred to the Jinyintan Hospital in Wuhan,Hubei Province in central China.They were all related to the Huanan Seafood Wholesale Market As similar cases began to be reported in Wuhan,57-year-old Zhang Dingyu,P resident of the hospital,was on high alert.His decades of clinical experience told him it was not an ordinary infectious disease.     

For a Consensual COVID-19 Reduction Strategy

Cooperation on medical research,trade and among institutions is the only answer On March 24,U.S.President Donald Trump asked for medical equipment and test kits in a 23-minute phone call with Moon Jae-in,President of the Republic of Korea(ROK).The call was said to be arranged after an urgent request by Trump.The U.S.president has repeatedly bragged about the U.S.preparedness for the novel coronavirus disease(COVID-19),but the surging confirm ed cases and increasing death toll tell another story.